Related Experiment Video
Updated: Jun 30, 2025

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
Published on: February 16, 2020
Integrated plasma proteomics identifies tuberculosis-specific diagnostic biomarkers
Hannah F Schiff1,2, Naomi F Walker3, Cesar Ugarte-Gil4,5
1NIHR Biomedical Research Centre, School of Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
New protein biomarkers in the blood can accurately detect active pulmonary tuberculosis (TB) and distinguish it from other respiratory illnesses. This discovery offers a promising tool for near-patient screening to combat the global TB pandemic.
Area of Science:
- Biochemistry and Molecular Biology
- Infectious Diseases
- Biomarker Discovery
Background:
- The global tuberculosis (TB) pandemic necessitates novel biomarkers for identifying infectious patients.
- Plasma protein profiles in active pulmonary TB may serve as diagnostic indicators.
- Distinguishing TB from other respiratory infections requires improved diagnostic tools.
Purpose of the Study:
- To identify and validate plasma protein biomarkers for diagnosing pulmonary tuberculosis.
- To differentiate TB cases from healthy individuals and patients with other respiratory infections.
- To assess the potential of these biomarkers for near-patient screening assays.
Main Methods:
- Employed a sensitive tandem mass spectrometry approach to analyze plasma proteins in South African and Peruvian cohorts.
- Utilized bioinformatic analyses, including linear modeling and network correlation, to identify differentially expressed proteins.
- Validated candidate biomarkers in diverse ethnic cohorts using antibody-based proximity extension assays.
Main Results:
- Identified 118 differentially expressed proteins through rigorous bioinformatic analysis.
- Confirmed TB-specific host biomarkers with high sensitivity and specificity.
- A 6-protein panel (FETUB, FCGR3B, LRG1, SELL, CD14, ADA2) effectively differentiated pulmonary TB patients.
Conclusions:
- The 6-protein biomarker panel meets World Health Organization criteria for a TB triage test.
- These novel biomarkers show potential for development into near-patient TB screening assays.
- The findings contribute to closing the case-detection gap in the global TB pandemic.
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
MALDI-TOF Mass Spectrometry
Matrix-assisted laser desorption ionization (MALDI) is a commonly...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Peptide Identification Using Tandem Mass Spectrometry
This technique helps gather information regarding the protein from which the peptide was obtained and to study the peptides’ amino acid sequence. Identifying peptides from a complex mixture is an important component of the growing field of...

